Phase 2 trial of CV301 vaccine plus atezolizumab in advanced urothelial carcinoma

Role Of Vaccines In Urothelial Carcinoma

Saul Analysis: Atezolizumab In Urothelial Carcinoma Patients

Neoadjuvant Atezolizumab For Non-metastatic Urothelial Cancer

Safety Results From Phase 3b Strong Trial Of Durvalumab In Patients With Urinary Tract Carcinoma

Key Trials In Bladder Cancer From Asco Gu 2022

Webinar: Hepatic Arterial Infusion (hai) Pump Trial For Icc At Ohsu

Liquid Biopsies And Tumor-informed Ctdna Profiling In Metastatic Urothelial Carcinoma

Transfemoral Viv Tavr Using 23mm Evolut Pro Valve - May 2021

New, Novel Navitor™ Tavi Valve With Active Paravalvular Leak-sealing Technology - Europcr 2021

Astellas Data From Skylight 1™ And Skylight 2™ Phase 3 Trials Of Fezolinetant For The Treatment

Bioprosthetic Aortic Viv Tavr After Valve Fracture And Evolut Pro Implantation

Ultimate Aortic Cases- Cvi 2020 Cme Webcast Series

Corevalve Evolut-r Tavr (26mm) Via Percutaneous Femoral Access - August 2015 Structural Live Case

Optimal Tavi Outcomes In The Active Patient - Pcr Valves E-course 2020

Randomized Trial Of Evolut And Sapien In Patients With Small Annuli - Pcr Valves E-course 2020

Corevalve Evolut-r Tavr (34mm) Via Percutaneous Femoral Access Structural Heart Live - Dec 14, 2016

Transcatheter Valve Replacement (tavr) And Savr-update On Outcome

Mini Medical School: Interventional Cardiology / Trans-aortic Valve Replacement (tavr)

Navitor, A Tavr Solution With An Active Paravalvular Leak-sealing Technology - Pcr Tokyo Valves 2021